Endoscopy 2025; 57(S 02): S80-S81
DOI: 10.1055/s-0045-1805252
Abstracts | ESGE Days 2025
Oral presentation
Stomach Pot Pourri 04/04/2025, 08:30 – 09:30 Room 124+125

Accelerated Balloon-Retrograde Transvenous Obliteration (a-BRTO): a Real-World Analysis of Results in the Management of Gastric Variceal (GV) Bleeding at a Tertiary Gastrointestinal Bleeding Centre in Spain

C Valdivia Krag
1   Hospital Costa del Sol, Marbella, Spain
2   Hospital Universitario Costa del Sol, Marbella, Spain
,
D S Ortiz Chimbo
3   Rio Hortega University Hospital, Valladolid, Spain
4   Hospital Universitario Reina Sofia, Córdoba, Spain
,
J Jurado García
5   Hospital Universitario Reina Sofía, Cordoba, Spain
,
A Gonzalez-Galilea
6   Hospital Universitario Reina Sofía, Córdoba, Spain
,
J J Espejo Herrero
5   Hospital Universitario Reina Sofía, Cordoba, Spain
,
P B Garcia Jurado
6   Hospital Universitario Reina Sofía, Córdoba, Spain
› Author Affiliations
 

Aims Gastric Variceal (GV) bleeding represents a significant clinical challenge due to its high mortality rate, which has been reported to be as high as 45% at six months, despite the fact that it is less common than esophageal varices. Therapeutic options, which combine endoscopic and interventional radiology approaches, are scarce, complex, and limited to specialised centres, hindering robust evidence to guide clinical decisions. This study evaluates the clinical outcomes of accelerated-BRTO (a-BRTO), a modified technique that reduces the balloon occlusion time from the conventional 4-24 hours, thereby minimising complications. The results aim to improve the applicability and safety of this promising approach to the management of GV bleeding.

Methods A descriptive and retrospective study was conducted at the Reina Sofía University Hospital, a tertiary gastrointestinal bleeding centre in southern Spain. Clinical and technical outcomes of all a-BRTO performed by an Interventional Radiology Unit over the past nine years (2016-2024) were evaluated. In addition, technical and clinical complications that occurred during and after the procedure, as well as the time to rebleeding and mortality, if any, were evaluated using descriptive statistical tools and Kaplan-Meier analysis [1] [2] [3] [4] [5].

Results Of the 20 patients who underwent a-BRTO, 16 (80%) were male, with a median age of 64 years (IQR 38-80) and a Charlson Comorbidity Index of 6.5 (IQR 3-14). Most patients (95%) had hepatic portal hypertension, 65% had alcohol-related liver disease, and 25% were on anticoagulants or antiplatelets. Median Meld-Na Score was 11 (IQR 6-24). Index bleeding occurred a median of 6.8 years after cirrhosis diagnosis, requiring blood transfusions in 85% of patients (median 2 units per-patient). At gastroscopy, 45%, 50%, and 5% of GOV2, IGV1, and IGV2 varices were identified, respectively. The a-BRTO procedure was successfully performed in 16 (80%) cases, with four technical complications (20%), with one intra-procedural death. Balloon occlusion lasted a median of 75 minutes (IQR 30-180). Over a median follow-up of 15 months (0-82), no additional procedure-related deaths occurred. Four rebleeding episodes were observed (three from GV, median time of 90 days), without related mortality. Cirrhosis decompensation occurred in 30% of patients, including encephalopathy (15%), ascites (10%), and hydrothorax (5%), with minimal thrombotic complications reported.

Conclusions The a-BRTO technique proved to be both effective and safe for the secondary prophylaxis of GV bleeding, with 3 (18.8%) cases of GV rebleeding observed during the follow-up period. Technical complications occurred in 4 (20%) patients, with one procedure-related death reported. Despite the adequate nine-year study period, the number of procedures performed was notably low, highlighting the importance of referring these patients to experienced centres to achieve the best possible clinical outcomes.



Publication History

Article published online:
27 March 2025

© 2025. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK.. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology [Internet]. 1992 [cited 2024 Apr 19];16(6):1343–9. Available from https://pubmed.ncbi.nlm.nih.gov/1446890/
  • 2 Deliwala SS, Hussain M, Ponnapalli A, Igbinedion SO, Bachuwa G, Bansal A.. Accelerated balloon-retrograde transvenous obliteration (BRTO): an effective tool in the Arsenal against isolated gastric varices (IGV). BMJ Case Rep 2021; 14 (09): e244405
  • 3 Henry Z, Patel K, Patton H, Saad W.. AGA Clinical Practice Update on Management of Bleeding Gastric Varices: Expert Review. Clinical Gastroenterology and Hepatology 2021; 19 (06): 1098-1107.e1
  • 4 Lee EW, Eghtesad B, Garcia-Tsao G, Haskal ZJ, Hernandez-Gea V, Jalaeian H. et al. AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage. Hepatology 2024; 79 (01): 224-50
  • 5 Luo X, Xiang T, Wu J, Wang X, Zhu Y, Xi X. et al. Endoscopic Cyanoacrylate Injection Versus Balloon-Occluded Retrograde Transvenous Obliteration for Prevention of Gastric Variceal Bleeding: A Randomized Controlled Trial. Hepatology [Internet]. 2021 Oct 1 [cited 2024 Apr 19];74(4):2074–84. Available from https://pubmed.ncbi.nlm.nih.gov/33445218/